CA Patent

CA2484592A1 — A fluid dispensing device

Assigned to Glaxo Group Ltd · Expires 2003-11-20 · 22y expired

What this patent protects

A fluid dispensing device (5, 105, 205, 305, 405, 505) is disclosed having a housing (9, 109, 209, 309, 409, 509) and a fluid discharge device (8, 108, 208, 308, 408, 508). The fluid discharge device (8, 108, 208, 308, 408, 508) is arranged to be actuated by one or more levers (2…

USPTO Abstract

A fluid dispensing device (5, 105, 205, 305, 405, 505) is disclosed having a housing (9, 109, 209, 309, 409, 509) and a fluid discharge device (8, 108, 208, 308, 408, 508). The fluid discharge device (8, 108, 208, 308, 408, 508) is arranged to be actuated by one or more levers (20, 21; 120, 121; 170; 220 , 221; 320, 321; 420, 421; 520) so as to apply a force transversely to the flu id discharge device (8, 108, 208, 308, 408, 508) which is used to move a container (30, 130, 230, 330, 430, 530) forming part of the fluid discharge device (8, 108, 208, 308, 408, 508) along a longitudinal axis of the fluid discharge device (8, 108, 208, 308, 408, 508) to cause actuation of a pump forming part of the fluid discharge device (8, 108, 208, 308, 408, 508).A pr e- load means (28; 27, 28; 39,40; 41, 42, 44; 144, 47a, 47b; 150, 152, 153; 224 , 227; 342; 424x, 446; 425a; 427, 428; 560, 561) is used to prevent actuation of the pump until a pre-determined force is applied to each lever (20, 21; 120, 121; 170; 220, 221; 320, 321; 420, 421; 520) of sufficient magnitude to guarantee the production of a well developed efficient spray from the fluid dispensing device (5, 105, 205, 305, 405, 505).

Drugs covered by this patent

Patent Metadata

Patent number
CA2484592A1
Jurisdiction
CA
Classification
Expires
2003-11-20
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.